Lazard Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-35,541
| Closed | -$163K | – | 2553 |
|
|
2025
Q1 | $163K | Buy |
35,541
+11,778
| +50% | +$54K | ﹤0.01% | 1684 |
|
|
2024
Q4 | $113K | Sell |
23,763
-79,349
| -77% | -$377K | ﹤0.01% | 1766 |
|
|
2024
Q3 | $483K | Buy |
103,112
+98,516
| +2,144% | +$461K | ﹤0.01% | 1365 |
|
|
2024
Q2 | $25K | Buy |
4,596
+3,266
| +246% | +$17.8K | ﹤0.01% | 2007 |
|
|
2024
Q1 | $5K | Sell |
1,330
-1,307
| -50% | -$4.91K | ﹤0.01% | 1902 |
|
|
2023
Q4 | $11K | Sell |
2,637
-9,047
| -77% | -$37.7K | ﹤0.01% | 2094 |
|
|
2023
Q3 | $50K | Buy |
11,684
+1,966
| +20% | +$8.41K | ﹤0.01% | 1859 |
|
|
2023
Q2 | $64K | Buy |
9,718
+7,041
| +263% | +$46.4K | ﹤0.01% | 1747 |
|
|
2023
Q1 | $18K | Sell |
2,677
-995
| -27% | -$6.69K | ﹤0.01% | 2074 |
|
|
2022
Q4 | $27K | Hold |
3,672
| – | – | ﹤0.01% | 2078 |
|
|
2022
Q3 | $36K | Hold |
3,672
| – | – | ﹤0.01% | 1928 |
|
|
2022
Q2 | $40K | Hold |
3,672
| – | – | ﹤0.01% | 1909 |
|
|
2022
Q1 | $41K | Sell |
3,672
-28
| -0.8% | -$313 | ﹤0.01% | 1836 |
|
|
2021
Q4 | $58K | Buy |
3,700
+481
| +15% | +$7.54K | ﹤0.01% | 1670 |
|
|
2021
Q3 | $55K | Sell |
3,219
-328
| -9% | -$5.6K | ﹤0.01% | 1641 |
|
|
2021
Q2 | $76K | Hold |
3,547
| – | – | ﹤0.01% | 1429 |
|
|
2021
Q1 | $53K | Buy |
3,547
+963
| +37% | +$14.4K | ﹤0.01% | 1412 |
|
|
2020
Q4 | $33K | Buy |
2,584
+1,805
| +232% | +$23.1K | ﹤0.01% | 1539 |
|
|
2020
Q3 | $7K | Sell |
779
-2,822
| -78% | -$25.4K | ﹤0.01% | 1519 |
|
|
2020
Q2 | $41K | Sell |
3,601
-3,062
| -46% | -$34.9K | ﹤0.01% | 1283 |
|
|
2020
Q1 | $69K | Buy |
6,663
+3,663
| +122% | +$37.9K | ﹤0.01% | 1086 |
|
|
2019
Q4 | $49K | Buy |
3,000
+1,704
| +131% | +$27.8K | ﹤0.01% | 1066 |
|
|
2019
Q3 | $17K | Buy |
+1,296
| New | +$17K | ﹤0.01% | 1121 |
|